echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Panlong Pharmaceutical cancels its wholly-owned subsidiary

    Panlong Pharmaceutical cancels its wholly-owned subsidiary

    • Last Update: 2021-04-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On April 13, Shaanxi Panlong Pharmaceutical Group Co.


    The announcement stated that the 14th meeting of the third board of directors held by the company reviewed and approved the "Proposal on Canceling the Subsidiary Gansu Panlong Pharmaceutical Co.


    According to the announcement, according to the actual operation and business conditions of the wholly-owned subsidiary Gansu Panlong Pharmaceutical Co.


    According to the 2020 annual performance report of Panlong Group, during the reporting period, the company achieved operating income of 670,058,900 yuan, an increase of 9.


    It is worth noting that as of December 31, 2020, its subsidiary Gansu Panlong had total assets of 169,639.


    However, Panlong Pharmaceutical Group stated that the cancellation of Gansu Panlong will not have a significant impact on the company's overall business development and profitability, and will not harm the interests of the company and shareholders.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.